YSG Fundamental Analysis - YATSEN HOLDING LTD-ADR

Fundamental Rating

Taking everything into account, YSG scores 4 out of 10 in our fundamental rating. YSG was compared to 36 industry peers in the Personal Care Products industry. YSG has a great financial health rating, but its profitability evaluates not so good. YSG is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

YSG had negative earnings in the past year.

In the past 5 years YSG always reported negative net income.

In the past 5 years YSG reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -13.07%, YSG is doing worse than 77.78% of the companies in the same industry.

Looking at the Return On Equity, with a value of -17.08%, YSG is in line with its industry, outperforming 44.44% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-13.07%
ROE	-17.08%
ROIC	N/A

ROA(3y)-15.56%

ROA(5y)-23.16%

ROE(3y)-19.51%

ROE(5y)-28.79%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

YSG's Gross Margin of 77.87% is amongst the best of the industry. YSG outperforms 86.11% of its industry peers.

YSG's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for YSG so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	77.87%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y4.93%

GM growth 5Y3.93%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

YSG does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for YSG has been reduced compared to 1 year ago.

Compared to 5 years ago, YSG has less shares outstanding

There is no outstanding debt for YSG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 0.16, we must say that YSG is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.16, YSG is doing worse than 75.00% of the companies in the same industry.

There is no outstanding debt for YSG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	0.16

ROIC/WACCN/A

WACC7.54%

2.3 Liquidity

A Current Ratio of 3.61 indicates that YSG has no problem at all paying its short term obligations.

The Current ratio of YSG (3.61) is better than 80.56% of its industry peers.

A Quick Ratio of 3.01 indicates that YSG has no problem at all paying its short term obligations.

YSG's Quick ratio of 3.01 is amongst the best of the industry. YSG outperforms 80.56% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.61
Quick Ratio	3.01

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

YSG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.61%, which is quite impressive.

YSG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.54%.

Measured over the past years, YSG shows a small growth in Revenue. The Revenue has been growing by 6.93% on average per year.

EPS 1Y (TTM)51.61%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)-36.54%

Revenue growth 3Y6.93%

Revenue growth 5YN/A

Sales Q2Q%47.24%

3.2 Future

Based on estimates for the next years, YSG will show a very strong growth in Earnings Per Share. The EPS will grow by 26.38% on average per year.

YSG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.56% yearly.

EPS Next Y68.58%

EPS Next 2Y25.32%

EPS Next 3Y31.98%

EPS Next 5Y26.38%

Revenue Next Year-10.54%

Revenue Next 2Y-4.29%

Revenue Next 3Y4.7%

Revenue Next 5Y8.56%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for YSG. In the last year negative earnings were reported.

Also next year YSG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

63.89% of the companies in the same industry are cheaper than YSG, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	1645.7

4.3 Compensation for Growth

A more expensive valuation may be justified as YSG's earnings are expected to grow with 31.98% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y25.32%

EPS Next 3Y31.98%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for YSG!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

YATSEN HOLDING LTD-ADR

NYSE:YSG (12/31/2025, 8:04:00 PM)

After market: 3.98 +0.09 (+2.31%)

3.89

-0.07 (-1.77%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryPersonal Care Products

Earnings (Last)11-17 2025-11-17/bmo

Earnings (Next)02-23 2026-02-23/bmo

Inst Owners28.96%

Inst Owner Change14.27%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap383.39M

Revenue(TTM)3.71B

Net Income(TTM)-528.30M

Analysts76.67

Price Target9.18 (135.99%)

Short Float %1.46%

Short Ratio0.98

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-18.18%

PT rev (3m)-18.18%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-41.88%

EPS NY rev (3m)-41.88%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)3.84%

Revenue NY rev (3m)3.84%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.72
P/FCF	N/A
P/OCF	N/A
P/B	0.87
P/tB	1.14
EV/EBITDA	1645.7

EPS(TTM)-0.54

EYN/A

EPS(NY)-0.23

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS5.43

BVpS4.48

TBVpS3.42

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-13.07%
ROE	-17.08%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	77.87%
FCFM	N/A

ROA(3y)-15.56%

ROA(5y)-23.16%

ROE(3y)-19.51%

ROE(5y)-28.79%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y4.93%

GM growth 5Y3.93%

F-ScoreN/A

Asset Turnover0.93

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	0
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.61
Quick Ratio	3.01
Altman-Z	0.16

F-ScoreN/A

WACC7.54%

ROIC/WACCN/A

Cap/Depr(3y)32.99%

Cap/Depr(5y)136.76%

Cap/Sales(3y)1.52%

Cap/Sales(5y)2.95%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)51.61%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next Y68.58%

EPS Next 2Y25.32%

EPS Next 3Y31.98%

EPS Next 5Y26.38%

Revenue 1Y (TTM)-36.54%

Revenue growth 3Y6.93%

Revenue growth 5YN/A

Sales Q2Q%47.24%

Revenue Next Year-10.54%

Revenue Next 2Y-4.29%

Revenue Next 3Y4.7%

Revenue Next 5Y8.56%

EBIT growth 1Y69.29%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year102.7%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-98.8%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-127.1%

OCF growth 3YN/A

OCF growth 5YN/A

YATSEN HOLDING LTD-ADR / YSG FAQ

Can you provide the ChartMill fundamental rating for YATSEN HOLDING LTD-ADR?

ChartMill assigns a fundamental rating of 4 / 10 to YSG.

What is the valuation status for YSG stock?

ChartMill assigns a valuation rating of 1 / 10 to YATSEN HOLDING LTD-ADR (YSG). This can be considered as Overvalued.

Can you provide the profitability details for YATSEN HOLDING LTD-ADR?

YATSEN HOLDING LTD-ADR (YSG) has a profitability rating of 2 / 10.

YATSEN HOLDING LTD-ADR (YSG) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

YATSEN HOLDING LTD-ADR / YSG FAQ

Can you provide the ChartMill fundamental rating for YATSEN HOLDING LTD-ADR?

What is the valuation status for YSG stock?

Can you provide the profitability details for YATSEN HOLDING LTD-ADR?